Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71


A prospective, observational cohort study to elicit adverse effects of antiretroviral agents in a remote resource-restricted tribal population of Chhattisgarh.

Singh H, Dulhani N, Tiwari P, Singh P, Sinha T.

Indian J Pharmacol. 2009 Oct;41(5):224-6. doi: 10.4103/0253-7613.58512.


A pharmacovigilance study in medicine department of tertiary care hospital in chhattisgarh (jagdalpur), India.

Singh H, Dulhani N, Kumar B, Singh P, Tewari P, Nayak K.

J Young Pharm. 2010 Jan;2(1):95-100. doi: 10.4103/0975-1483.62222.


A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.

Rajesh R, Vidyasagar S, Varma DM, Naik A, Hegde BM, Guddattu V, Kamath A.

Int J Risk Saf Med. 2013 Jan 1;25(1):53-65. doi: 10.3233/JRS-130580.


Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study.

Namme Luma H, Doualla MS, Choukem SP, Temfack E, Ashuntantang G, Achu Joko H, Koulla-Shiro S.

Pan Afr Med J. 2012;12:87. Epub 2012 Jul 27.


Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study.

Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI.

Br J Clin Pharmacol. 2008 Mar;65(3):396-406. Epub 2007 Dec 7.


Safety and Effectiveness of Highly Active Antiretroviral Therapy in Treatment-Naïve HIV Patients: Preliminary Findings of a Cohort Event Monitoring Study in Belarus.

Setkina S, Dotsenko M, Bondar S, Charnysh I, Kuchko A, Kaznacheeva A, Kozorez E, Dodaleva A, Rossa N.

Drug Saf. 2015 Apr;38(4):365-72. doi: 10.1007/s40264-015-0279-7.


Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.


Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.


Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.


Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.

Tabali M, Ostermann T, Jeschke E, Witt CM, Matthes H.

J Manag Care Pharm. 2012 Jul-Aug;18(6):427-38.


Adverse Drug Reactions to Antiretroviral Therapy in HIV-Infected Patients at the Largest Public Hospital in Nicaragua.

Lorío M, Colasanti J, Moreira S, Gutierrez G, Quant C.

J Int Assoc Provid AIDS Care. 2014 Sep-Oct;13(5):466-70. doi: 10.1177/2325957414535978. Epub 2014 Jun 16.


Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.

Eluwa GI, Badru T, Agu KA, Akpoigbe KJ, Chabikuli O, Hamelmann C.

BMC Clin Pharmacol. 2012 Feb 27;12:7. doi: 10.1186/1472-6904-12-7. Erratum in: BMC Clin Pharmacol. 2012;12:14. Agu, Kenneth A [added]; Chabikuli, Otto [added]; Hamelmann, Christoph [added].


Incidence of adverse drug reactions in human immune deficiency virus-positive patients using highly active antiretroviral therapy.

Srikanth BA, Babu SC, Yadav HN, Jain SK.

J Adv Pharm Technol Res. 2012 Jan;3(1):62-7. doi: 10.4103/2231-4040.93557.


HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India.

Anwikar SR, Bandekar MS, Smrati B, Pazare AP, Tatke PA, Kshirsagar NA.

Int J Risk Saf Med. 2011;23(3):163-9. doi: 10.3233/JRS-2011-0532.


Adverse Drug Reaction Profile in Patients on Anti-tubercular Treatment Alone and in Combination with Highly Active Antiretroviral Therapy.

Sadiq S, Khajuria V, Tandon VR, Mahajan A, Singh JB.

J Clin Diagn Res. 2015 Oct;9(10):FC01-4. doi: 10.7860/JCDR/2015/13452.6652. Epub 2015 Oct 1.


Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.

Jha N, Bajracharya O, Namgyal T.

Kathmandu Univ Med J (KUMJ). 2007 Oct-Dec;5(4):504-10.


Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.

Lobo MG, Pinheiro SM, Castro JG, Momenté VG, Pranchevicius MC.

BMC Pharmacol Toxicol. 2013 Jan 8;14:5. doi: 10.1186/2050-6511-14-5.


Adverse Drug Reactions in HIV/AIDS Patients at a Tertiary Care Hospital in Penang, Malaysia.

Khan K, Khan AH, Sulaiman SA, Soo CT, Akhtar A.

Jpn J Infect Dis. 2016;69(1):56-9. doi: 10.7883/yoken.JJID.2014.246. Epub 2015 Jun 12.


Incidence of antiretroviral adverse drug reactions in pregnant women in two referral centers for HIV prevention of mother-to-child-transmission care and research in Rio de Janeiro, Brazil.

Santini-Oliveira M, Friedman RK, Veloso VG, Cunha CB, Pilotto JH, Marins LM, João EC, Torres TS, Grinsztejn B.

Braz J Infect Dis. 2014 Jul-Aug;18(4):372-8. doi: 10.1016/j.bjid.2013.11.008. Epub 2014 Mar 22.

Supplemental Content

Support Center